Nature 2005 Meredith. Wadman - Abstracts

Nature 2005 Meredith. Wadman
TitleSubjectAuthors
Appetite downer awaits approval.Zoology and wildlife conservationMeredith Wadman
Cancer chief embraces top drugs job.(Andrew von Eschenbach)(United States Food and Drug Administration)Zoology and wildlife conservationMeredith Wadman
Journal grows suspicious of Vioxx data.Zoology and wildlife conservationMeredith Wadman
Licensing fees slow advance of stem cells.Zoology and wildlife conservationMeredith Wadman
Medicare compels heart patients to enlist in follow-up research.Zoology and wildlife conservationMeredith Wadman
NIH workers see red over revised rules for conflicts of interest.Zoology and wildlife conservationMeredith Wadman
No longer the upstart.(for Biotechnology Industry Organization )Zoology and wildlife conservationMeredith Wadman
Painkiller in the dock.Zoology and wildlife conservationMeredith Wadman
Path to approval proves rocky for copycat biodrugs.Zoology and wildlife conservationMeredith Wadman
Race is on for flu vaccine.Zoology and wildlife conservationMeredith Wadman
Salt sellers challenge US health agency using data-quality act.Zoology and wildlife conservationMeredith Wadman
Swooping for biotech.Zoology and wildlife conservationMeredith Wadman
The healing touch.Zoology and wildlife conservationMeredith Wadman
The safety catch.Zoology and wildlife conservationMeredith Wadman
US set to endorse human pesticide testing.Zoology and wildlife conservationMeredith Wadman
Vioxx may go back on sale after scraping FDA panel.Zoology and wildlife conservationMeredith Wadman
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.